Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Methotrexate vs Triamcinolone in Localized Psoriasis
NCT05408208Unknown
- Sponsor
- Sohag University
- Start
- May 2022
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of methotrexate in psoriasis (2 arms), sponsored by Sohag University. Primary endpoint: Efficacy Of Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis. Status: unknown.
02
Drugs
methotrexate
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT05408208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05408208.